Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-14T05:16:36.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed. This appears to be a minor software version update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-02-07T05:48:05.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated the Study Record Dates to display 'Last Update Submitted that Met QC Criteria'. The page footer now includes 'No FEAR Act Data' and a new 'Revision: v3.4.0' note.
    Difference
    0.2%
    Check dated 2026-01-24T01:24:22.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3; this is a minor system update that does not affect the study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T01:31:04.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-19T13:16:26.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor UI/metadata update and does not affect the study content.
    Difference
    0.1%
    Check dated 2025-11-28T04:09:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.